Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Merlo

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Haematologica|April 28, 2010
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Head & Neck|May 7, 2014
In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapyPablo Secades, Inés Saenz de Santa-María, Anna Merlo, et al.
Clinical & Developmental Immunology|February 10, 2012
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Frontiers in Immunology|March 15, 2017
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4<sup>+</sup> T CellsElena Muraro, Anna Merlo, Debora Martorelli, et al.
Journal of Clinical Medicine|February 13, 2025
MitraClip Procedure in Advanced Heart Failure and Severe Mitral Regurgitation: Case Report and Literature ReviewCamilla Cirelli, Anna Merlo, Alice Calabrese, et al.
Plos One|November 11, 2014
Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugsIsabella Monia Montagner, Anna Merlo, Gaia Zuccolotto, et al.
Journal of Clinical Medicine|March 28, 2024
Right Ventricular Dysfunction before and after Cardiac Surgery: Prognostic ImplicationsAnna Merlo, Camilla Cirelli, Enrico Vizzardi, et al.
Oncoscience|June 23, 2015
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancerIsabella Monia Montagner, Anna Merlo, Debora Carpanese, et al.
Journal of Clinical Medicine|June 28, 2023
Prognostic Value of sST2 in Heart FailureEdoardo Sciatti, Anna Merlo, Claudio Scangiuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 2010
Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumorsAnna Merlo, Riccardo Turrini, Sara Bobisse, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Haematologica|April 28, 2010
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Head & Neck|May 7, 2014
In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapyPablo Secades, Inés Saenz de Santa-María, Anna Merlo, et al.
Clinical & Developmental Immunology|February 10, 2012
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Frontiers in Immunology|March 15, 2017
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4<sup>+</sup> T CellsElena Muraro, Anna Merlo, Debora Martorelli, et al.
Journal of Clinical Medicine|February 13, 2025
MitraClip Procedure in Advanced Heart Failure and Severe Mitral Regurgitation: Case Report and Literature ReviewCamilla Cirelli, Anna Merlo, Alice Calabrese, et al.
Plos One|November 11, 2014
Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugsIsabella Monia Montagner, Anna Merlo, Gaia Zuccolotto, et al.
Journal of Clinical Medicine|March 28, 2024
Right Ventricular Dysfunction before and after Cardiac Surgery: Prognostic ImplicationsAnna Merlo, Camilla Cirelli, Enrico Vizzardi, et al.
Oncoscience|June 23, 2015
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancerIsabella Monia Montagner, Anna Merlo, Debora Carpanese, et al.
Journal of Clinical Medicine|June 28, 2023
Prognostic Value of sST2 in Heart FailureEdoardo Sciatti, Anna Merlo, Claudio Scangiuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 2010
Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumorsAnna Merlo, Riccardo Turrini, Sara Bobisse, et al.
Pageof 5